Healthtech Startup CURAPOD Raises Rs 20 Cr to Scale Wearable Pain Management Technology

Written By :  Farhat Nasim
Published On 2026-02-10 13:38 GMT   |   Update On 2026-02-10 13:38 GMT
Advertisement

New Delhi: Healthtech startup CURAPOD has raised Rs 20 crore (around USD 2.2 million) in a pre-Series A funding round led by V3 Ventures, 3i Partners and Ideaspring Capital, according to an Entrackr report.

The startup is backed by medical technology firm Litemed, the filing noted.

The fresh capital will be used to accelerate research and development, enhance CURAPOD’s wearable device and companion app, scale manufacturing and expand go-to-market efforts, the company said. It also plans to strengthen its direct-to-consumer presence, expand partnerships with gyms, physiotherapy centres, and sports medicine networks, and improve operational efficiencies.

Advertisement

Founded in 2022 by Sri Velliyur and Surya Maguluri, CURAPOD develops wearable, non-invasive pain management devices focused on musculoskeletal conditions. The brand’s device uses photobiomodulation therapy and is designed to address conditions such as back pain, neck pain, knee pain, joint disorders, muscle stiffness and sports-related injuries.

The FDA-registered device supports more than 30 musculoskeletal conditions and offers a drug-free alternative to conventional pain management methods. CURAPOD follows a clinician-led adoption model and is expanding its footprint across India.

The funding comes amid strong investor interest in healthtech startups in India, with the sector continuing to draw capital for solutions spanning diagnostics, digital therapeutics and wearable medical technologies, reports Entrackr.

Tags:    
Article Source : with inputs

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News